At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
Launched by SAMSUNG MEDICAL CENTER · Mar 18, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Those aged 50 or older
- • Those who are indicated for and are scheduled to undergo reverse total shoulder arthroplasty (RTSA)
- • Those who carry an Android or iOS smartphone
- • Those who voluntarily decided to participate and gave written consent after hearing a detailed explanation of this study
- • Exclusion criteria
- • Those who have difficulty using the application due to severe underlying diseases, neuromusculoskeletal diseases, cognitive or visual impairments, etc.
- • Those with concomitant diseases such as neurological or visual impairments or uncontrolled cardiovascular disorders that make it difficult to participate in rehabilitation exercises
- • Other people who, as determined by a medical professional, should not perform rehabilitation exercises without supervision
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported